DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of "Hold" from Analysts – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
DBV Technologies S.A. (NASDAQ:DBVT – Get Rating) has been given an average rating of “Hold” by the six analysts that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $5.50.
A number of research firms have weighed in on DBVT. StockNews.com began coverage on shares of DBV Technologies in a research report on Friday. They set a “hold” rating for the company. HC Wainwright reissued a “buy” rating and set a $10.00 target price on shares of DBV Technologies in a research report on Tuesday, May 3rd. JMP Securities reissued a “buy” rating and set a $5.00 target price on shares of DBV Technologies in a research report on Wednesday, June 8th. Finally, The Goldman Sachs Group lowered shares of DBV Technologies from a “buy” rating to a “neutral” rating and cut their target price for the stock from $6.00 to $1.50 in a research report on Monday, May 9th.
Several institutional investors and hedge funds have recently made changes to their positions in the company. FNY Investment Advisers LLC acquired a new position in shares of DBV Technologies during the fourth quarter valued at about $32,000. Envestnet Asset Management Inc. acquired a new position in DBV Technologies in the fourth quarter worth about $43,000. Finally, BlackRock Inc. raised its position in DBV Technologies by 16.5% in the first quarter. BlackRock Inc. now owns 687,341 shares of the company’s stock worth $1,093,000 after purchasing an additional 97,412 shares in the last quarter. 19.33% of the stock is owned by institutional investors and hedge funds.
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Shares of NASDAQ:DBVT opened at $2.49 on Friday. The stock has a market capitalization of $304.45 million, a PE ratio of -3.19 and a beta of 1.56. DBV Technologies has a 1 year low of $1.15 and a 1 year high of $5.99. The firm has a fifty day moving average price of $1.86 and a 200 day moving average price of $1.63.
DBV Technologies (NASDAQ:DBVT – Get Rating) last issued its quarterly earnings data on Monday, May 2nd. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.32. The business had revenue of $2.55 million during the quarter, compared to the consensus estimate of $2.20 million. On average, equities analysts anticipate that DBV Technologies will post -0.69 earnings per share for the current year.
DBV Technologies Company Profile (Get Rating)
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults.
Featured Articles

• Get a free copy of the StockNews.com research report on DBV Technologies (DBVT)
• MarketBeat: Week in Review 7/4 – 7/8
• AT&T (NYSE:T) Is Its Cheaper Valuation Worth A Buy?
• Levi Strauss Proves Resilient For Dividend Investors 
• Altria Group (NYSE MO): A Contentious High-Yield Dividend Stock
• 3 Grocery Stocks That Can Help Take a Bite Out of Inflation

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DBV Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and DBV Technologies wasn’t on the list.
While DBV Technologies currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Today’s interview is a little different, in that you get a LOT of market perspective from someone who’s been analyzing stocks from the ground up, for more than three decades. In this conversation, Kate chats with Nancy Zambell, the chief analyst for the Cabot Money Club Letter – and Nancy has a really deep and varied background in the financial industry – as she mentions in this interview, she’s been a banker, real estate professional, and a stock market analyst.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.

source